ArticleMolecular cancer therapeutics2021

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.

Daisuke Okajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.